17 new stories
1. Bosch patents Pellet 3D printer without refill pauses - 3Druck.com
Domain: 3druck.comThe documents are patents, not product announcements. Whether Bosch intends to commercialize such a machine is not indicated in the filings. Large ...
2. Case: Patents/Procedure (Fed. Cir.) - Bloomberg Law News
Domain: news.bloomberglaw.comCase: Patents/Procedure (Fed. Cir.) June 25, 2026, 6:15 AM PDT. The Federal Circuit affirmed the decision of a federal district court in Virginia ...
3. Case: Patents/Summary Judgment (4th Cir.) - Bloomberg Law News
Domain: news.bloomberglaw.comCase: Patents/Summary Judgment (4th Cir.) June 24, 2026, 10:14 AM PDT. The Fourth Circuit affirmed the decision of a federal district court in ...
4. Valence AI Raises $5 Million And Secures U.S. Patents For Real-Time Emotional Detection ...
Domain: pulse2.comValence AI announced $5 million in total funding and the issuance of two U.S. patents covering the company's proprietary audio signal processing ...
5. Samsung Faces Legal Challenge Over LED Patents in the US - SammyGuru
Domain: sammyguru.com | Companies: Samsung... patents. These patents are centered around opto-semiconductor technologies that improve the performance of LED and microLED devices. The ...
6. Monthly statistics: Patents, trade marks and designs: May 2026 - GOV.UK
Domain: gov.ukThese statistics include monthly data for patents, trade marks and designs.
7. Patent Enablement Considerations for Pharma and Biotech Inventions in Vietnam
Domain: lexology.com” In pharmaceutical and biotechnology patents, this requirement is more complicated and subject to more rigorous assessment. The Patent ...
8. Amgen v Sanofi: EPO appeal withdrawal confirms European alignment - Lexology
Domain: lexology.com | Companies: AmgenFurther to our recent article discussing the global dispute between Sanofi/Regeneron and Amgen over the validity of patents covering therapeutic…
9. Substance Over Form: How The Delhi And Madras High Courts Are Rewriting The Rules For ...
Domain: livelaw.in... Patents Act, 1970. If the Controller of Patents refuses the application, the applicant may challenge that refusal before the High Court. This ...
10. Red and green flags: how IP firms pick funding partners | Managing Intellectual Property
Domain: managingip.comChoosing the right one will hinge on how clear a firm is about its long-term goals. Topics. AnalysisTrademarksPatentsEuropeInternationalNews · sukanya ...
11. Full Federal Circuit Won't Consider DePuy's Challenge To Patent Witness Ruling - Mealey's
Domain: mealeys.com... physician who claimed that the DePuy entities induced surgeons to infringe certain claims of his patents.
12. New Zealand | Patents Amendments Act 2026: The Great Kiwi Divisional Dash
Domain: mondaq.comNew Zealand's Parliament has passed the Patents Amendments Bill 2025, addressing a long-standing inconsistency in patent law regarding divisional ...
13. Dickinson Wright recognized in Legal 500 United States 2026 Edition
Domain: nnbw.comDispute Resolution – General Commercial Disputes – Mid-Market ($0-250m); Industry Focus – Cannabis; Intellectual Property – Patents: Licensing ...
14. Hero Patents New Budget Commuter Bike – Likely For Export Markets - RushLane
Domain: rushlane.comCombined with models like Passion and Glamour, entry-level motorcycles make up nearly 90% of Hero's overall volumes. Hero Patents New Bike. The newly ...
15. A black market for 'fake patents' is a new poison in Indian research - The Hindu
Domain: thehindu.comA black market for fake patents in India threatens research integrity, as companies exploit academics for academic reputation gains.
16. Congress deserves evidence on patents, not more slogans - The News-Enterprise
Domain: thenewsenterprise.comThe evidence tells a different story: Generic competition routinely arrives years before all patents associated with a medicine expire, and more than ...
17. ANTITRUST NEWS—4th Cir.: FTC files amicus brief challenging monopolization ... - VitalLaw.com
Domain: vitallaw.comThe J&J acquisition of Momenta included four manufacturing patents for ustekinumab biosimilars (Momenta manufacturing patents). CareFirst alleged ...
